Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
75 hedge funds and large institutions have $37.7M invested in Genesis Healthcare, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 11 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
1% more funds holding
Funds holding: 74 → 75 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $58.3M → $37.7M (-$20.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$2.37M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$496K |
| 3 |
Renaissance Technologies
New York
|
+$382K |
| 4 |
FWC
First Washington Corp
Seattle,
Washington
|
+$378K |
| 5 |
JP Morgan Chase
New York
|
+$344K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$627K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$284K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$269K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$246K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$243K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
76
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$30K | -11,363 | Closed |
|
77
Citigroup
New York
| – | -$4.77K | -2,243 | -95% |
|
|
MAM
78
Meeder Asset Management
Dublin,
Ohio
| – | -$4K | -1,548 | Closed |
|
79
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2.61K | -1,230 | -86% |
|
80
Barclays
London,
United Kingdom
| – | -$1.56K | -734 | -86% |
|
81
UBS Group
Zurich,
Switzerland
| – | -$1K | -515 | Closed |
|
|
TDC
82
Thompson Davis & Co
Richmond,
Virginia
| – | -$1K | -500 | Closed |
|
83
Simplex Trading
Chicago,
Illinois
| – | -$691 | -325 | -65% |
|
|
QI
84
QS Investors
New York
| – | -$1K | -147 | Closed |
|
85
SEI Investments
Oaks,
Pennsylvania
| – | +$104 | +49 | New |
|
86
Group One Trading
Chicago,
Illinois
| – | +$212 | +100 | New |
|
GEN Hedge Fund Activity: Q2 2017 in Review
75 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2017, worth a combined $37.7M — down 35% from $58.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GEN positions and 11 closed out — a net gain of 1 holder — while 25 added to existing stakes and 21 trimmed.
The largest buyer was Columbia Pacific Advisors, adding an estimated $2.37M. The largest seller was Vanguard Group, cutting an estimated $627K.
- 75 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2017, up from 74 in Q1 2017.
- Funds reported $37.7M of Genesis Healthcare, Inc. stock for Q2 2017, down 35% quarter-over-quarter.
- 12 funds opened new Genesis Healthcare, Inc. positions in Q2 2017 and 11 closed out, a net change of +1 holder.
- The largest Genesis Healthcare, Inc. buyer in Q2 2017 was Columbia Pacific Advisors, an estimated $2.37M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2017 was Vanguard Group, an estimated $627K sold.
Based on aggregated 13F filings for Q2 2017.